The abstract is read at the publisher; the summary is JClub's.
In longitudinal asthma transcriptome datasets, 23 of 34 evaluable asthma-related genes show significant diurnal rhythmicity, with preserved peak-time patterns across cohorts.
- Why it matters: Immune pathways in asthma and its treatments vary by time of day, but it is unclear which biologic targets have measurable circadian expression peaks for biomarker discovery or dosing optimization.
- What they did: Using bulk RNA-seq and microarray data (GSE113883, GSE223613, and GSE39445), the study tested 46 biologic-related targets for diurnal variation, then estimated baseline, phase, and peak-time for genes with Benjamini-Hochberg FDR < 0.05.
- The result: Clock genes validated rhythmicity (12 of 16 evaluable), and peak times were cross-cohort consistent for targets such as GATA3, STAT6, CXCL8, IL-5RA, FcRE1, and IL1RL1, supporting time-aware biomarker and therapy optimization.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.